Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death Preliminary safety trial results in over 6,000 patients with gout being evaluated. Lingua Italiano Leggi tutto su Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death
